Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Van Praet

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcomeValérie Fonteyne, Nicolaas Lumen, Piet Ost, et al.
Biomed Research International|February 20, 2015
Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcomeTom Claeys, Charles Van Praet, Nicolaas Lumen, et al.
European Urology Focus|September 26, 2022
Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER TrialValérie Fonteyne, Charles Van Praet, Piet Ost, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 28, 2018
Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized studyJeroen Van Besien, Pieter Uvin, Emmanuel Weyne, et al.
BJU International|September 20, 2025
Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancerLies Van den Eynde, Piet Ost, Wesley Verla, et al.
Urologia Internationalis|January 5, 2017
Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate CancerFilip Poelaert, Candy Kumps, Nicolaas Lumen, et al.
Clinical Genitourinary Cancer|September 17, 2024
Rare type of Bellini Duct Carcinoma in a Patient With Cacchi-Ricci Disease: A Case Report and Mini-ReviewAntonio Franco, Thomas Tailly, Camille Berquin, et al.
BMC Medical Imaging|October 7, 2024
Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancerDaan De Maeseneer, Pieter De Visschere, Mats Van den Broecke, et al.
Translational Andrology and Urology|June 23, 2021
Analyzing the learning curves of a novice and an experienced urologist for transrectal magnetic resonance imaging-ultrasound fusion prostate biopsyEmanuel Darius Cata, Charles Van Praet, Iulia Andras, et al.
Journal of Clinical Pathology|April 1, 2017
Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profileTijl Vermassen, Katharina D'Herde, Dominique Jacobus, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 11, 2013
Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcomeValérie Fonteyne, Nicolaas Lumen, Piet Ost, et al.
Biomed Research International|February 20, 2015
Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcomeTom Claeys, Charles Van Praet, Nicolaas Lumen, et al.
European Urology Focus|September 26, 2022
Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER TrialValérie Fonteyne, Charles Van Praet, Piet Ost, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 28, 2018
Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized studyJeroen Van Besien, Pieter Uvin, Emmanuel Weyne, et al.
BJU International|September 20, 2025
Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancerLies Van den Eynde, Piet Ost, Wesley Verla, et al.
Urologia Internationalis|January 5, 2017
Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naïve Prostate CancerFilip Poelaert, Candy Kumps, Nicolaas Lumen, et al.
Clinical Genitourinary Cancer|September 17, 2024
Rare type of Bellini Duct Carcinoma in a Patient With Cacchi-Ricci Disease: A Case Report and Mini-ReviewAntonio Franco, Thomas Tailly, Camille Berquin, et al.
BMC Medical Imaging|October 7, 2024
Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancerDaan De Maeseneer, Pieter De Visschere, Mats Van den Broecke, et al.
Translational Andrology and Urology|June 23, 2021
Analyzing the learning curves of a novice and an experienced urologist for transrectal magnetic resonance imaging-ultrasound fusion prostate biopsyEmanuel Darius Cata, Charles Van Praet, Iulia Andras, et al.
Journal of Clinical Pathology|April 1, 2017
Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profileTijl Vermassen, Katharina D'Herde, Dominique Jacobus, et al.
Pageof 8